Artificial metalloenzymes generally consist of a synthetic (organo)metallic catalyst incorporated into a protein. Asymmetric catalysis by such metalloenzymes could result by virtue of the chiral protein environment. Now, redox-sensitive anchoring enables reversible incorporation of an iridium catalyst for transfer hydrogenation.
This is a preview of subscription content, log in via an institution to check access.
Change history
26 September 2018
In the version of this News & Views article originally published, in ref. 3, ‘https://doi.org/10.1038/s41929-018-124-3 was incorrect and should have read ‘https://doi.org/10.1038/s41929-018-124-3’. This has now been corrected in all versions.
References
Wilson, M. E. & Whitesides, G. M. J. Am. Chem. Soc. 100, 306–307 (1978).
Muñoz Robles, V. et al. J. Am. Chem. Soc. 136, 15676–15683 (2014).
Raines, D. J. et al. Nat. Catal. https://doi.org/10.1038/s41929-018-0124-3 (2018).
Schwizer, F. et al. J. Chem. Rev. 118, 142–231 (2018).
Blanco, V., Leigh, D. A. & Marcos, V. Chem. Soc. Rev. 44, 5341–5370 (2015).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Okuda, J. Reversible catalyst anchoring . Nat Catal 1, 639–640 (2018). https://doi.org/10.1038/s41929-018-0149-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41929-018-0149-7
- Springer Nature Limited
This article is cited by
-
Synthetic prodrug design enables biocatalytic activation in mice to elicit tumor growth suppression
Nature Communications (2022)